TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
M & U Drugge AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,706
|
1,885
|
2,050 |
| Financial expenses |
10
|
9
|
4 |
| Earnings before taxes |
-281
|
-82
|
32 |
| EBITDA |
-269
|
-71
|
41 |
| Total assets |
52
|
234
|
305 |
| Current assets |
52
|
234
|
302 |
| Current liabilities |
64
|
52
|
52 |
| Equity capital |
-184
|
95
|
166 |
| - share capital |
52
|
51
|
47 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
-353.8%
|
40.6%
|
54.4% |
| Turnover per employee |
853
|
942
|
1,025 |
| Profit as a percentage of turnover |
-16.5%
|
-4.4%
|
1.6% |
| Return on assets (ROA) |
-521.2%
|
-31.2%
|
11.8% |
| Current ratio |
81.2%
|
450.0%
|
580.8% |
| Return on equity (ROE) |
152.7%
|
-86.3%
|
19.3% |
| Change turnover |
-213
|
-310
|
308 |
| Change turnover % |
-11%
|
-14%
|
18% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.